Board Meeting27 Oct 2026, 04:40 pm
Dr. Lal PathLabs Board to Consider Q2 Results & Interim Dividend
AI Summary
Dr. Lal PathLabs Ltd has announced that its Board of Directors will convene on Wednesday, November 04, 2026. The primary agenda items include the consideration and approval of the un-audited financial results (Standalone & Consolidated) for the Quarter and Half Year ended September 30, 2026. Additionally, the Board will evaluate the possibility of declaring a second interim dividend for the Financial Year 2026-27 on the company's equity shares. This meeting follows a previous intimation dated September 25, 2026.
Key Highlights
- Board meeting scheduled for November 04, 2026.
- To consider un-audited financial results for Q2 FY27.
- Will also consider declaration of 2nd interim dividend for FY27.
- Results will be standalone and consolidated.
Price Impact
More from LALPATHLAB